Oprasta 0.8
Drug Category |
|
Medicinal form |
Vials |
Active ingredient |
|
Concentration |
0.8mg |
Manufacturer |
|
Price |
650 EGP |
Uses
Zoledronic acid is a potent inhibitor of bone resorption. It is used for hypercalcaemia of malignancy, in a single dose of4 mg administered by intravenous infusion over 15 minutes.
Adverse effect : renal failure, reported in patients who have received Doses of 8 mg
Uses: for the prevention of skeletal events in patients with advanced bone malignancies at a Dose of 4 mg every 3 to 4 week+A24:C24s. The treatment ma be re eated if necessar after at least 7 days.
Note: The information provided about this drug does not substitute for consulting a doctor.
The doctor answers your questions quickly
Are you experiencing any symptoms at the moment? Now many specialist doctors are ready to help you.
Calculators
Calculator for Health is a very useful tool to help individuals better understand and manage their health. By providing measurable data, users can make better informed decisions to maintain or improve their well-being.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies